Eaglenos (晶捷生物科)

Nanjing, China

Point-of-Care Devices Diagnostics Diabetes Cardiovascular Disease

Eaglenos Co., Ltd., established in 2017, brings together top talents in chemistry, materials, electronics, software, machinery, biomedical engineering and other fields. Adhering to the core values of "quality, innovation, cooperation and accountability", Eaglenos is committed to the innovation in electrochemistry, microfluidics, signal acquisition and automation technologies. We have launched a series of accurate POCT products for various diseases such as diabetes, hyperuricemia, cardiovascular and cerebrovascular diseases. Eaglenos started its formal operation in June 2018 and has continuously expanded and developed. With an investment of 150 million RMB, the company has an R&D base of over 9,000 square meters in Jiangbei New Area, including international standard R&D labs, GMP production workshops and automated production lines, etc.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Eaglenos (晶捷生物科) on @MedStartr Today #Diabetes #CardiovascularDisease #CerebrovascularCardiovascularDiseases #Hyperlipidemia #PointOfCareDevices #Diagnostics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/CZ0reM6E2Pk

Get Involved in Eaglenos (晶捷生物科)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2017
Website: www.eaglenos.com/

Disease Areas

Diabetes Cardiovascular Disease Cerebrovascular & Cardiovascular Diseases Hyperlipidemia

Technologies

MicrofluidicsAutomationPoint-of-Care DiagnosticsBiosensors

🌐Website

What do you think of Eaglenos (晶捷生物科)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.